Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Stem Cells and Antibodies in Drug Discovery Europe 2018

Stem Cells and Antibodies in Drug Discovery Europe 2018

Date: Thursday, 24 May 2018 - Friday, 25 May 2018
Location: Cambridge, UK


Keynote Speakers

Gary Gintant

Gary Gintant
Senior Research Fellow, Abbvie

Paul French

Paul French
Professor, Department of Physics and Photonics Group, Imperial College London

Robert Williams

Robert Williams
Chief Drug Development Scientist, Cancer Research UK

Stefan Dubel

Stefan Dubel
Full Professor and Director, Technische Universit├Ąt Braunschweig

Matthew Daniels

Matthew Daniels
Wellcome Trust Intermediate Clinical Fellow, Honorary Consultant Cardiologist, University of Oxford

Stephen Helliwell

Stephen Helliwell
Senior Investigator, Novartis Institutes for BioMedical Research

David Hay

David Hay
Chair of Tissue Engineering, MRC Centre for Regenerative Medicine, University of Edinburgh

Overview

Stem Cells and Antibodies in Drug Discovery 2018 and Antibodies in Drug Discovery 2018 and High-Content & Phenotypic Screening 2018 -- Explore the emerging trends and technologies impacting Drug Discovery, circa 2018.

Stem Cells in Drug Discovery 2018: Hear from and network with researchers who are currently screening for efficacy and toxicity using iPS cell lines, and those responsible for developing the techniques and technologies. There will also be discussions on industry and regulatory developments that are shaping the future of stem cell usage in drug discovery.

Antibodies in Drug Discovery 2018:
The focus is to explore the latest developments in the design and engineering of antibodies in relation to the burgeoning field of biotherapeutics. Topics to be addressed include, engineering challenges and techniques, new technologies and business hurdles when developing antibodies, the latest developments in autoimmune and infectious disease research. If you work in antibody drug discovery research you will benefit from the expert knowledge of academic and industry leaders, whilst networking with the technology providers.

Information and Local Registration Facilities for this Conference are also available in:

Japanese  |  Korean  |  Chinese (Simplified)  |  Chinese (Traditional)

Agenda Topics

  • 3D-Cell Based Models
  • Antibodies for New Targets
  • Antibody Drug Conjugates (ADCs)
  • Antibody Screening
  • Humanized Single Domain Antibodies for Research and Therapeutic Applications
  • iPSC-derived Cells for Toxicity Testing & Screening
  • Monoclonal Antibodies
  • Scale Up and Quality Control
  • Screening Technologies, Instrumentation and Reagents
  • Stem Cells in Drug Discovery and Toxicity Screening
  • Targeting Ion Channels with Biologics

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44 (0) 1206 501654

Confirmed Speakers to date

Louise Affleck, UK Team Leader, Cisbio Bioassays
Hugh Byrne, Professor, Dublin Institute of Technology
Win-Yan Chan, Research Scientist, UCB
Wing Chang, R&D Director, STEMCELL Technologies
Jacqueline Chuah, Lab Officer, Institute of Bioengineering and Nanotechnology, A*Star
Maciej Daniszewski, PhD Student, University of Melbourne
Davide Danovi, Director, Cell Phenotyping Platform, Kings College London
Giovanna Defilippi, Sr. Field Applications Scientist, Axion BioSystems
Nicholas Hannan, Assistant Professor, University of Nottingham
Ben Haworth, Cellular Imaging Application Specialist, GE Life Sciences
Simon Hufton, Section Head Molecular Immunology, National Institute for Biological Standard and Control (NIBSC)
Jason Lo, Account Manager (EU + UK), Applied StemCell, Inc.
Hua Rong Lu, Senior Principal Scientist, Discovery Sciences, Janssen Pharmaceutical NV
Peter O'Brien, Head of Clinical Pathology, University College Dublin
Alice P├ębay, Associate Professor, Principal Research Fellow, University of Melbourne & Centre for Eye Research Australia
Alexander Schreiner, Team Leader Biological Applications, PerkinElmer
Sanjay Sinha, BHF Senior Research Fellow, University of Cambridge
Masatoshi Suzuki, Associate Professor, Department of Comparative Biosciences and Stem Cell & Regenerative Medicine Center, University of Wisconsin-Madison
Tristan Vaughan, Vice President, R&D, Antibody Discovery and Protein Engineering, MedImmune Ltd
E. Sally Ward, Professor, Texas A&M University Health Science Center
Joanne Young, Senior Scientist, CYTOO SA


Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Add to Calendar ▼2018-05-24 00:00:002018-05-25 00:00:00Europe/LondonStem Cells and Antibodies in Drug Discovery Europe 2018Stem Cells and Antibodies in Drug Discovery Europe 2018 in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com